DA
Dare Bioscience, Inc.
DARE · NASDAQ
$0.73 -0.89% (-$0.01)
1M -4.96%
Market Cap $10.9M
P/E Ratio -
Div. Yield -
ROE 748.08%
Bulios Fair Price
$0.97
33.7% upside
Trenutna cena
$0.73
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DARE trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
5 /100
Expensive P/S 7.96x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 53.12%
Book val. growth 36.52%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 89.45%
FCF margin 860.62%
Net margin 804.37%
Quality
1 /100
Poor ROIC 179.10%
Asset turnover 0.06x
ROE 748.08%
Debt
16 /100
High Current ratio 0.99x
Int. coverage -53.95x
Debt/Equity N/A
Stability
23 /100
Unstable Beta 1.01x
Profitable years 0
Rev. volatility 6,070.94%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DARE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sabrina Martucci Johnson
Employees
23
Headquarters
San Diego
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report